Ernexa Therapeutics Inc.(ERNA)

$3.91—Stale · unknown old

Ernexa Therapeutics Inc.(ERNA)

NASDAQ • Last print unknown ago

$3.91—Stale · unknown old

ERNA(ERNA)

ERNA

Q4 2026 EPS Estimate

$-3.84

Nov 6, 2026 · Reports before open

No analyst ratings available

No analyst price targets available for ERNA

Analyst coverage may not be available for this symbol

Forward Growth Estimates (YoY)

FY2027

Rev—

EPS—

FY2028

Rev—

EPS—

FY2029

Rev—

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$75M	—	—	—	—
Low	$75M	—	—	—	—
High	$75M	—	—	—	—
EBITDA Avg	$881,570	—	—	—	—
Low	$881,570	—	—	—	—
High	$881,570	—	—	—	—
EBIT Avg	$-2M	—	—	—	—
Low	$-2M	—	—	—	—
High	$-2M	—	—	—	—
Net Income Avg	$-5M	$-469,242	$-320,396	$-363,284	$-416,263
Low	$-5M	$-469,242	$-320,396	$-363,284	$-416,263
High	$-5M	$-469,242	$-320,396	$-363,284	$-416,263
EPS Avg	$-18.02	$-1.86	$-1.27	$-1.44	$-1.65
Low	$-18.02	$-1.86	$-1.27	$-1.44	$-1.65
High	$-18.02	$-1.86	$-1.27	$-1.44	$-1.65
Analysts (Rev / EPS)	1 / 1	— / 1	— / 1	— / 1	— / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
EBITDA Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
EBIT Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
Net Income Avg	$-5M	$-6M	$-1.15B	$-976M	$-1.06B	$-2M	$-2M	$-3M
Low	$-5M	$-6M	$-1.15B	$-976M	$-1.06B	$-2M	$-2M	$-3M
High	$-5M	$-6M	$-1.15B	$-976M	$-1.06B	$-2M	$-2M	$-3M
EPS Avg	$-3.84	$-4.76	$-975.00	$-825.00	$-900.00	$-1.95	$-2.11	$-2.40
Low	$-3.84	$-4.76	$-975.00	$-825.00	$-900.00	$-1.95	$-2.11	$-2.40
High	$-3.84	$-4.76	$-975.00	$-825.00	$-900.00	$-1.95	$-2.11	$-2.40
Analysts (Rev / EPS)	— / 1	— / 1	— / 1	— / 1	— / 1	— / 1	— / 1	— / 1

No recent analyst actions

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance